| __timestamp | ImmunityBio, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 20140000 |
| Thursday, January 1, 2015 | 226206000 | 37173000 |
| Friday, January 1, 2016 | 94391000 | 48616000 |
| Sunday, January 1, 2017 | 53821000 | 108488000 |
| Monday, January 1, 2018 | 35463000 | 244622000 |
| Tuesday, January 1, 2019 | 46456000 | 287000000 |
| Wednesday, January 1, 2020 | 71318000 | 354000000 |
| Friday, January 1, 2021 | 135256000 | 186000000 |
| Saturday, January 1, 2022 | 102708000 | 151000000 |
| Sunday, January 1, 2023 | 129620000 | 232600000 |
| Monday, January 1, 2024 | 267474000 |
In pursuit of knowledge
In the dynamic world of biotechnology, understanding financial trends is crucial. Over the past decade, Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc. have showcased distinct patterns in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced ImmunityBio in SG&A spending, peaking in 2020 with a 354% increase from 2014. Meanwhile, ImmunityBio's SG&A expenses saw a dramatic spike in 2015, surging by over 5000% compared to the previous year, before stabilizing. This divergence highlights Ionis's steady growth strategy versus ImmunityBio's initial aggressive expansion. As of 2023, Ionis's SG&A expenses were approximately 80% higher than ImmunityBio's, reflecting their differing operational focuses. These insights offer a window into the strategic priorities of these biotech giants, providing investors and analysts with valuable context for future financial decisions.
Zoetis Inc. and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Madrigal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ImmunityBio, Inc.
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.